Attached files

file filename
10-Q - FORM 10-Q - Innovation Pharmaceuticals Inc.ctix_10q.htm
EX-31.2 - CERTIFICATION - Innovation Pharmaceuticals Inc.ctix_ex312.htm
EX-32.1 - CERTIFICATION - Innovation Pharmaceuticals Inc.ctix_ex321.htm
EX-10.37 - INTELLECTUAL PROPERTY ACQUIRED FROM POLYMEDIX - Innovation Pharmaceuticals Inc.ctix_ex1037.htm
EX-31.1 - CERTIFICATION - Innovation Pharmaceuticals Inc.ctix_ex311.htm
EX-10.39 - LEASE BETWEEN CELLCEUTIX CORPORATION AND CUMMINGS PROPERTIES LLC - Innovation Pharmaceuticals Inc.ctix_ex1039.htm
EX-10.38 - MATERIAL TRANSFER AGREEMENT WITH BETH ISRAEL DEACONESS - Innovation Pharmaceuticals Inc.ctix_ex1038.htm
EXHIBIT 32.2
  
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
 
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Cellceutix Corporation, a Nevada corporation (the "Company"), does hereby certify, to such officer's knowledge, that: 
 
The Quarterly Report on Form 10-Q for the quarter ended March 31, 2014 of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company. 
 
A signed original of this written statement required by Section 906 has been provided to Cellceutix Corporation and will be retained by Cellceutix Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
 
       
Dated: May 12, 2014
By:
/s/ Leo Ehrlich  
    Leo Ehrlich  
    Chief Executive Officer and Chief Financial Officer and Chairman of the Board of Directors (Principal Executive, Accounting and Financial Officer)